Oxford scientists in the money
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Two Oxford scientists could make a paper profit of pounds 500,000 when the science group they founded comes to the stock market.
Oxford GlycoSciences was founded 10 years ago by Raymond Dwek and Raj Parekh, in collaboration with Oxford University. The university also stands to make a healthy profit from the flotation.
The group specialises in producing technology used by drug companies to help identify proteins that cause diseases. The group has recently signed a deal with Incyte to develop databases for the world's biggest pharmaceutical companies. The group is also carrying out clinical studies on two liver cancer treatments.
Oxford GlycoSciences is looking to raise pounds 25m-pounds 30m which will value the group at between pounds 75m and pounds 100m. It has already raised pounds 30m from equity backers, such as Warburg Pincus and The Wellcome Trust.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments